AI manufacturing software specialist IntelliAM AI listed on AQSE in London last week. The company develops AI models to proactively increase the operational efficiency of manufacturing companies.
IntelliAM [AQSE:INT] harnesses the data generated by manufacturing machine and operational systems to provide actionable insights for its clients. This includes areas like productivity, reliability and supply chain optimisation. Its technology can also help manufacturing companies become more energy efficient, which is critical with power prices so high,
- IPO Radar: CoreWeave, Hinge Health, Venture Global
- IPO Radar: CoreWeave, Etihad Airways, Mixue
- IPO Radar: 7 Eleven, the biotech sector and Bally’s Chicago
IntelliAM recently combined its manufacturing asset management consultancy with its more recently developed AI platform. CEO Tony Clayotn said he thought IntelliAM now has the ability to help manufacturers reduce unscheduled downtime and improve producer operating efficiencies.
Shortly after listing on AQSE, IntelliAM also confirmed the acquisition of 53 Degrees North Engineering.
Smurfit Kappa and WestRock re-list as Smurfit Westrock following combination
Shares in sustainable packaging firm Smurfit Westrock [LON:SWR] started trading in London on Monday, with a primary listing in New York as well. This follows on from the previously announced combination of Smurfit Kappa and WestRock.
Smurfit Westrock operates in 40 countries tapping into the expertise of more than 100,000 people. Its focus is on renewable and recyclable packaging solutions. The combination of the two companies has created a major player in the global sustainable packaging market.
Shares in Smurfit Kappa have been de-listed effective immediately. This includes from Euronext in Dublin. The company was previously a FTSE 100 constituent and likely to remain so going forward.
EY says Hong Kong market’s IPO drought will end soon
George Chan, the global IPO leader for EY, said that he thought the IPO market in Hong Kong would improve in the next five years. Hong Kong has been seeing some issues as an IPO venue since the pandemic. Chan said he thought that a further interest rate cut in Hong Kong might be supportive of more IPO appetite.
Morrison Foerster reported that its Hong Kong capital markets team is “very busy” and that it has a strong IPO pipeline in place for the second half of the year.
Some of the headwinds Hong Kong has been facing include high US interest rates and regulatory scrutiny, not to mention political tensions between China and the US which are unlikely to change if Donald Trump gets into power.
Mainland China and Hong Kong both saw a sharp decline in listings in the first half of this year.
e-therapeutics raises GBP 28m via M&G-led fundraise
Unlisted companies liquidity venue JP Jenkins said that e-therapeutics has completed a GBP 28m fund raise that was managed by M&G Investment Management and Richard Griffiths. e-therapeutics integrates computational power and biological data to discover life-transforming RNAi medicines.
The subscription by M&G was conditional on clearance under the National Security and Investment Act (2021) which is now complete.
Proceeds from the fundraise will be used to advance e-therapeutics’ GalOmic pipeline assets towards the clinic and initiative clinical trials on one program. The company also plans to use the proceeds to keep its early pipeline well populated, and accelerate development and integration of cutting edge AI systems into its HepNet computational platform.
JP Jenkins said that e-therapeutics was planning to pursue a listing on NASDAQ in due course.
